Figure 4
Impact of HPV 16/18 vaccine on HPV and cervical cancer epidemiology in the UK. (A) Oncogenic HPV prevalence; (B) CIN 1 prevalence; (C) CIN 2+CIN 3 prevalence; (D) cervical cancer incidence.
Figure 4 | British Journal of Cancer
Impact of HPV 16/18 vaccine on HPV and cervical cancer epidemiology in the UK. (A) Oncogenic HPV prevalence; (B) CIN 1 prevalence; (C) CIN 2+CIN 3 prevalence; (D) cervical cancer incidence.
